Recruiting Gaucher Disease Studies in Minneapolis
About Gaucher Disease Clinical Trials in Minneapolis
Gaucher disease is an inherited metabolic disorder caused by deficiency of the enzyme glucocerebrosidase, leading to accumulation of fatty substances in organs. It is the most common lysosomal storage disorder. Treatment includes enzyme replacement therapy and substrate reduction therapy.
There are currently 1 gaucher disease clinical trials recruiting participants in Minneapolis, MN. These studies are seeking a combined 50 participants. Research is being sponsored by University of Minnesota. Clinical trial participation is free and participants receive study-related medical care at no cost.
Gaucher Disease Clinical Trials in Minneapolis — FAQ
Are there gaucher disease clinical trials in Minneapolis?
Yes, there are 1 gaucher disease clinical trials currently recruiting in Minneapolis, MN. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Minneapolis?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Minneapolis research site will contact you about next steps.
Are clinical trials in Minneapolis free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Minneapolis studies also compensate for your time and travel.
What gaucher disease treatments are being tested?
The 1 active trials in Minneapolis are testing new therapies including novel drugs, biologics, and treatment approaches for gaucher disease.
Data updated March 2, 2026 from ClinicalTrials.gov